Bringing the fundamentals into focus…
Back to Nurix Therapeutics, Inc.
How Nurix Therapeutics, Inc. stacks up
NRIX · against 347 other Healthcare companies of similar size
Overall
84/ 100
Near the top of its peers.
Ranked #8 of 348 · scores higher than 98% of peers
Bars: peers in each 10-point band of the overall score13 peers with an overall score of 80–89, including NRIX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around NRIX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 6 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 7 | 12.3B CNY (≈$1.7B) | 85 | 83 | 86 | 99 | 0 / 2 | |
| 8 | 19.7B HKD (≈$2.5B) | 84 | 84 | 98 | 87 | 0 / 2 | |
| 8 | 2.7B USD | 84 | 75 | 98 | 99 | 1 / 2 | |
| 10 | 12.9B HKD (≈$1.7B) | 83 | 99 | 64 | 98 | 0 / 2 | |
| 11 | 2.2B USD | 82 | 90 | 92 | 96 | 1 / 2 | |
| 12 | 2.05T KRW (≈$1.5B) | 81 | 83 | 62 | 95 | 0 / 2 | |
| 12 | 18.3B DKK (≈$2.7B) | 81 | 86 | 74 | 86 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score